Access the full text.
Sign up today, get DeepDyve free for 14 days.
Huan Meng, Min Xue, T. Xia, Yan-Li Zhao, F. Tamanoi, J. Stoddart, J. Zink, A. Nel (2010)
Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.Journal of the American Chemical Society, 132 36
M. Smyth, M. Teng, J. Swann, K. Kyparissoudis, D. Godfrey, Y. Hayakawa (2006)
CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer1The Journal of Immunology, 176
S. Wrzesinski, Y. Wan, R. Flavell (2007)
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer TherapyClinical Cancer Research, 13
V. Torchilin (2005)
Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 4
Nicolas Acquavella, H. Kluger, J. Rhee, L. Farber, H. Tara, S. Ariyan, D. Narayan, W. Kelly, M. Sznol (2008)
Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell CancerJournal of Immunotherapy, 31
L. Carvalho, R. Ruiz, K. Scaramuzzi, E. Marengo, J. Matos, D. Tambourgi, M. Fantini, O. Sant'Anna (2010)
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.Vaccine, 28 50
M. Kano, Y. Bae, C. Iwata, Y. Morishita, M. Yashiro, Masako Oka, T. Fujii, A. Komuro, K. Kiyono, M. Kaminishi, K. Hirakawa, Y. Ouchi, N. Nishiyama, K. Kataoka, K. Miyazono (2007)
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signalingProceedings of the National Academy of Sciences, 104
Jason Park, S. Wrzesinski, E. Stern, M. Look, J. Criscione, R. Ragheb, Steven Jay, Stacey Demento, A. Agawu, Paula Limon, A. Ferrandino, David Gonzalez, A.‐K. Habermann, R. Flavell, T. Fahmy (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.Nature materials, 11 10
C. Ashley, Eric Carnes, Genevieve Phillips, D. Padilla, Paul Durfee, Page Brown, Tracey Hanna, Juewen Liu, Brandy Phillips, Mark Carter, Nick Carroll, Xingmao Jiang, D. Dunphy, C. Willman, D. Petsev, Deborah Evans, A. Parikh, B. Chackerian, W. Wharton, D. Peabody, C. Brinker (2011)
The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid BilayersNature materials, 10
Jinjun Shi, Alexander Votruba, O. Farokhzad, R. Langer (2010)
Nanotechnology in drug delivery and tissue engineering: from discovery to applications.Nano letters, 10 9
R. Flavell, Shomyseh Sanjabi, S. Wrzesinski, P. Licona-Limón (2010)
The polarization of immune cells in the tumour environment by TGFβNature Reviews Immunology, 10
Huan Meng, M. Liong, T. Xia, Zongxi Li, Zhaoxia Ji, J. Zink, A. Nel (2010)
Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.ACS nano, 4 8
G. Maltzahn, Ji-Ho Park, K. Lin, Neetu Singh, C. Schwöppe, R. Mesters, W. Berdel, E. Ruoslahti, M. Sailor, S. Bhatia (2011)
Nanoparticles that communicate in vivo to amplify tumour targeting.Nature materials, 10 7
Nanoparticle-enabled, sustained delivery of soluble hydrophilic cytokines and hydrophobic inhibitors engages the innate and adaptive immune systems to fight cancer.
Nature Materials – Springer Journals
Published: Sep 24, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.